AI Summary
- Recognise immuno-metabolic mechanisms as central contributors to psychiatric disorder pathophysiology and treatment response.
- Prioritise translational pipelines linking mechanistic studies, validated biomarkers and clinical trials to move findings into practice.
- Target personalised interventions, repurposing metabolic and anti-inflammatory agents with patient stratification and rigorous outcome measures.
Br J Psychiatry. 2026 Sep 1:1-2. doi: 10.1192/bjp.2026.10756. Online ahead of print.
NO ABSTRACT
PMID:42676161 | DOI:10.1192/bjp.2026.10756
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
